Candriam SCA’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20M Buy
693,869
+204,958
+42% +$5.89M 0.12% 165
2025
Q1
$16.4M Buy
+488,911
New +$16.4M 0.1% 181
2024
Q2
Sell
-88,005
Closed -$4.12M 697
2024
Q1
$4.12M Sell
88,005
-200,006
-69% -$9.36M 0.03% 375
2023
Q4
$10.2M Buy
+288,011
New +$10.2M 0.07% 245